Adsorptive Granulocyte and Monocyte Apheresis versus Prednisolone in Patients with Corticosteroid-Dependent Moderately Severe Ulcerative Colitis
Authors:
- Hiroyuki HanaiHHHiroyuki Hanai
- Fumitoshi WatanabeFWFumitoshi Watanabe
- Masami YamadaMYMasami Yamada
- Yoshihiko SatoYSYoshihiko Sato
- Ken TakeuchiKTKen Takeuchi
- Takayuki IidaTITakayuki Iida
- Kotaro TozawaKTKotaro Tozawa
- Tatsuo TanakaTTTatsuo Tanaka
- Yasushi MaruyamaYMYasushi Maruyama
- Isao MatsushitaIMIsao Matsushita
- Yasushi IwaokaYIYasushi Iwaoka
- Kazuto KikuchKKKazuto Kikuch
- 1 January 2004
- journal article
- clinical trial
- Published by S. Karger AG in Digestion
- Vol. 70 (1) , 36-44
Abstract
Background/Aim: Active ulcerative colitis (UC) is often associated with increased peripheral granulocytes and monocytes/macrophages which show activation behavior and prolonged survival time. Further, mucosal granulocyte level parallels intestinal inflammation and can predict UC relapse. Accordingly, our aim was to see if adsorptive granulocyte/monocyte apheresis (GMA) can promote remission and spare steroid in patients with steroid-dependent (SD) UC. Methods: 69 SD patients, at the time of relapse, were randomly assigned to groups I (n = 46) and II (n = 23). The mean dose of prednisolone (PSL) was 12 mg/day/patient, CAI (clinical activity index) 9.2 in both groups. Group I patients were given up to 11 GMA sessions over 10 weeks with Adacolumn; in group II, the mean dose of PSL was increased to 30 mg/day/patient. Results: At week 12, 83% of group I and 65% of group II patients were in remission, CAI in group I was 1.7 (p < 0.001) and in group II, 2.5 (p < 0.001). Further, during the 12 weeks of treatment, the cumulative amount of PSL received per patient was 1,157 mg in group I and 1,938 mg in group II (p = 0.001). Conclusions: GMA appeared to be an effective adjunct to standard drug therapy of moderately severe UC by promoting remission and sparing steroids.Keywords
This publication has 43 references indexed in Scilit:
- Ig-binding Receptors on Human NK Cells as Effector and Regulatory Surface MoleculesInternational Reviews of Immunology, 2001
- Role of Cytokines in the Pathogenesis of Inflammatory Bowel DiseaseAnnual Review of Medicine, 2000
- Effect of iC3b binding to immune complexes upon the phagocytic response of human neutrophils: synergistic functions between FcγR and CR3FEBS Letters, 1995
- Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fibre model of intravascular arrestClinical and Experimental Immunology, 1995
- The production of cytokines by polymorphonuclear neutrophilsImmunology Today, 1995
- Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.Gut, 1994
- CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functionsClinical and Experimental Immunology, 1993
- Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence ofin vivoactivation in active diseaseClinical and Experimental Immunology, 1991
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- SulfasalazineDigestive Diseases and Sciences, 1983